Cancer Test

When uncommon, early-onset, or recurrent cancers occur within a family, it is recommended to study 89 key genes that may be associated with a hereditary origin of the disease.

Price

$799.00

USD

Would you like us to call you?

One of our agents will contact you

Comprehensive genetic testing for hereditary cancer that optimizes clinical decision-making.

Introduction

Get ahead of hereditary cancer risk with our advanced genetic testing. This comprehensive analysis examines 89 clinically relevant genes —including BRCA1 and BRCA2— to detect hereditary predispositions to cancers such as breast, ovarian, colorectal, and pancreatic cancer, among others. With this information, personalized prevention strategies can be developed, medical surveillance can be more accurately targeted, and tailored treatment plans can be designed.

Clinical Significance

[field_autop key="D1_Texto_1"]

Technical Specifications

[field_autop key="D2_Texto_2"]

Ideal Candidates for Testing

[field_autop key="D3_Texto_3"]

Clinical Utility and Impact

[field_autop key="D4_Texto_4"]

Conclusion

[field_autop key="D5_Texto_5"]

Testing Methodology

[field_autop key="D6_Texto_6"]

Genes Evaluated

[field_autop key="D7_Texto_7"]

Test Limitations

[field_autop key="D8_Texto_8"]

Regulatory Disclosures

[field_autop key="D9_Texto_9"]

References

[field_autop key="D10_Texto_10"]

All NGS panels have a turnaround time of 10 to 14 days for results.